Palomar Medical LuxV
This article was originally published in The Gray Sheet
Executive Summary
Acne market entry is signaled by expanded 510(k) indication April 2 for use of the pulsed light system handpiece to treat mild to moderate forms of the skin condition. The device, which targets the sebaceous glands, previously was cleared to treat pigmented lesions...
You may also be interested in...
J&J/Palomar Device Deal Aims To Bring Lasers To OTC Skin Care Market
Johnson & Johnson Consumer Companies is entering the aesthetic laser market through a partnership with Palomar Medical, announced Sept. 7
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.